| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| R&D Expense | $111K | -59.0% |
| SG&A Expense | $404K | +3.5% |
| Operating Income | -$2.2M | -3.4% |
| Interest Expense | $385K | -75.4% |
| Income Tax | $0 | — |
| Net Income | -$2.1M | +25.5% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Current Assets | $552K | +116.5% |
| Total Assets | $552K | +116.5% |
| Current Liabilities | $809K | -47.9% |
| Total Liabilities | $809K | -47.9% |
| Stockholders' Equity | -$257K | +80.2% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.2M | +33.6% |
| Financing Cash Flow | $1.4M | -25.7% |